World's Best Scientists 2026 revealed!
Carolyn F. Deacon

Carolyn F. Deacon

D-Index & Metrics

Medicine

D-Index
95
Citations
31526
World Ranking
10107
National Ranking
113

Carolyn F. Deacon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Carolyn F. Deacon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 267 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Carolyn F. Deacon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Carolyn F. Deacon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Carolyn F. Deacon is affiliated with the University of Copenhagen in Denmark and primarily works within the field of Medicine, with a focus on Endocrinology, Diabetes and Metabolism. Their research contributions span across several related subfields including Surgery, Molecular Biology, Oncology, and Cardiology and Cardiovascular Medicine.

Their main areas of study revolve around topics such as:

  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Metabolism, Diabetes, and Cancer
  • Neuropeptides and Animal Physiology
  • Diet and metabolism studies
  • Diabetes Management and Research
  • Peptidase Inhibition and Analysis

Carolyn F. Deacon has contributed to multiple publications in prominent journals, with frequent appearances in venues such as:

  • Diabetes Obesity and Metabolism
  • Frontiers in Endocrinology
  • Nature Reviews Endocrinology
  • Molecular Metabolism
  • JCI Insight

Selected recent papers with corresponding publication years and venues include:

  • Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus, 2020, Nature Reviews Endocrinology
  • What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?, 2021, Frontiers in Endocrinology
  • Glucose-dependent insulinotropic polypeptide (GIP), 2025, Molecular Metabolism
  • Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R-dependent manner, 2021, JCI Insight
  • Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism, 2021, Journal of the Endocrine Society

Frequent collaborators in their research include Jens J. Holst, Nicolai J. Wewer Albrechtsen, Sten Madsbad, Christoffer Martinussen, and Kirstine N. Bojsen-Møller. These coauthors appear regularly across publications and contribute collectively to the development of their field of study.

Best Publications

  • Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

    Tina Vilsbøll;Thure Krarup;Carolyn F. Deacon;Sten Madsbad

  • Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

    Carolyn F Deacon;Michael A Nauck;Maibritt Toft-Nielsen;Lone Pridal

  • Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

    C F Deacon;A H Johnsen;J J Holst

  • Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

    Lene Hansen;Carolyn F. Deacon;Cathrine Ørskov;Jens J. Holst

  • Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.

    Jens J. Holst;Carolyn F. Deacon

  • Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

    Gary A. Herman;Arthur Bergman;Catherine Stevens;Paul Kotey

  • Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review

    C. F. Deacon

  • The incretin system and its role in type 2 diabetes mellitus.

    Jens Juul Holst;Tina Vilsbøll;Carolyn F. Deacon

  • Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

    Carolyn F. Deacon;Michael A. Nauck;Juris Meier;Katrin Hücking

  • Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

    M. A. Nauck;I. Vardarli;C. F. Deacon;J. J. Holst

  • Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.

    C F Deacon;T E Hughes;J J Holst

  • Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity

    C. F. Deacon;L. B. Knudsen;K. Madsen;F. C. Wiberg

  • Therapeutic strategies based on glucagon-like peptide 1.

    Carolyn F. Deacon

  • Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes

    A. Mari;W. M. Sallas;Y. L. He;C. Watson

  • Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig.

    C. F. Deacon;L. Pridal;L. Klarskov;M. Olesen

  • The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice

    Bidda Rolin;Marianne O. Larsen;Carsten F. Gotfredsen;Carolyn F. Deacon

  • Secretion, Degradation, and Elimination of Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide in Patients with Chronic Renal Insufficiency and Healthy Control Subjects

    Juris J. Meier;Michael A. Nauck;Daniel Kranz;Jens J. Holst

  • Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

    J. J. Meier;B. Gallwitz;N. Siepmann;J. J. Holst

  • Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

    J. J. Holst;C. F. Deacon

  • Circulation and degradation of GIP and GLP-1.

    C. F. Deacon

Frequent Co-Authors

Jens J. Holst
Jens J. Holst University of Copenhagen
Sten Madsbad
Sten Madsbad University of Copenhagen
Filip K. Knop
Filip K. Knop University of Copenhagen
Juris J. Meier
Juris J. Meier Ruhr University Bochum
Bo Ahrén
Bo Ahrén Lund University
Michael A. Nauck
Michael A. Nauck Ruhr University Bochum
Michael Horowitz
Michael Horowitz University of Adelaide
Mette M. Rosenkilde
Mette M. Rosenkilde University of Copenhagen
Jens F. Rehfeld
Jens F. Rehfeld University of Copenhagen
Matthias Mann
Matthias Mann Max Planck Institute of Biochemistry

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online pathways in medicine and healthcare can offer flexibility and speed up your journey into advanced clinical roles. Many professionals are opting for accelerated programs, such as the shortest dnp programs, which allow nurses to quickly attain the highest level of clinical education. For those who prefer a less research-intensive route, there are dnp programs without dissertation, letting students focus on practical skills rather than lengthy research projects.

Entry into healthcare can also be streamlined with fast track medical programs, designed for those seeking to become Licensed Practical Nurses (LPNs) and start working in a clinical setting sooner. For registered nurses aiming to specialize in mental health, pursuing an advanced role through online psych np programs can open up new career opportunities with flexible study formats.

These online programs cater to diverse career ambitions, reduce time in school, and offer more accessible paths to high-demand roles within the field of medicine.

Best Scientists Citing Carolyn F. Deacon

Trending Scientists

Recently Published Articles